Background: An association of mental stress with atopic dermatitis is widely accepted. However, no long-term evaluation of psychophysiological reactivity over the course of disease has yet been performed. Objective: We examined whether atopic dermatitis patients have an increased psychophysiological reactivity compared to healthy controls and in between acute and disease-free phases, and whether they differ in psychological state and trait variables. Methods: Fifteen patients with atopic dermatitis underwent a stress test during acute exacerbation and after symptom improvement and were compared to matched controls. Results: Psychophysiological responsesto stress were not stronger in the patient group than in the controls. Nevertheless, the patients had a higher heart rate and lower vagal activity throughout the resting and stress phases at both examination times. The patients showed significantly higher anxiety, depression and emotional excitability, and self-ratings of inactivity clearly distinguished acute phases from remission. Conclusion: There is an increased vegetative excitability level in patients with atopic dermatitis, which cannot be attributed solely to increased disease activity.

Keywords:
Atopic dermatitis, Parasympathetic activity, Psychophysiology, Stress, Sympathetic activity
1.
Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980;92:44–47.
2.
Arnetz BB, Fjellner B, Eneroth P, Kallner A: Endocrine and dermatological concomitants of mental stress. Acta Derm Venereol Suppl (Stockh) 1991;156:9–12.
3.
Morren MA, Przybilla B, Bamelis M, Heykants B, Reynaers A, Degreef H: Atopic dermatitis: Triggering factors. J Am Acad Dermatol 1994;31:467–473.
4.
Buske-Kirschbaum A, Geiben A, Hellhammer D: Psychobiological aspects of atopic dermatitis: An overview. Psychother Psychosom 2001;70:6–16.
5.
Gieler U, Ehlers A, Hohler T, Burkard G: The psychosocial status of patients with endogenous eczema: A study using cluster analysis for the correlation of psychological factors with somatic findings. Hautarzt 1990;41:416–423.
6.
Ginsburg IH, Prystowsky JH, Kornfeld DS, Wolland H: Role of emotional factors in adults with atopic dermatitis. Int J Dermatol 1993;32:656–660.
7.
Kiriyama K, Sugiura H, Uehara M: Premenstrual deterioration of skin symptoms in female patients with atopic dermatitis. Dermatology 2003;206:110–112.
8.
Felten SY, Madden KS, Bellinger DL, Kruszewska B, Moynihan JA, Felten DL: The role of the sympathetic nervous system in the modulation of immune responses. Adv Pharmacol 1998;42:583–587.
9.
Bachen EA, Manuck SB, Cohen S, Muldoon MF, Raible R, Herbert TB, Rabin BS: Adrenergic blockade ameliorates cellular immune responses to mental stress in humans. Psychosom Med 1995;57:366–372.
10.
Herbert TB, Cohen S, Marsland AL, Bachen EA, Rabin BS, Muldoon MF, Manuck SB: Cardiovascular reactivity and the course of immune response to an acute psychological stressor. Psychosom Med 1994;56:337–344.
11.
Seiffert K, Hosoi J, Torii H, Ozawa H, Ding W, Campton K, Wagner JA, Granstein RD: Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol 2002;168:6128–6135.
12.
Grewe SR, Chan SC, Hanifin JM: Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: A possible mechanism for cyclic AMP-agonist hyporesponsiveness. J Allergy Clin Immunol 1982;70:452–457.
13.
Sawai T, Ikai K, Uehara M: Elevated cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from children with atopic dermatitis. Br J Dermatol 1995;132:22–24.
14.
Bos JD, Kapsenberg ML, Smitt JH: Pathogenesis of atopic eczema. Lancet 1994;343:1338–1341.
15.
Elenkov IJ, Chrousos GP: Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann NY Acad Sci 2002;966:290–303.
16.
Leung DY, Soter NA: Cellular and immunologic mechanisms in atopic dermatitis. J Am Acad Dermatol 2001;44:S1–S12.
17.
Schmid-Ott G, Jaeger B, Adamek C, Koch H, Lamprecht F, Kapp A, Werfel T: Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol 2001;107:171–177.
18.
Pincelli C, Fantini F, Giannetti A: Neuropeptides and skin inflammation. Dermatology 1993;187:153–158.
19.
Cooper KD: Atopic dermatitis: Recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128–137.
20.
Stander S, Steinhoff M: Pathophysiology of pruritus in atopic dermatitis: An overview. Exp Dermatol 2002;11:12–24.
21.
Faulstich ME, Williamson DA, Duchmann EG, Conerly SL, Brantley PJ: Psychophysiological analysis of atopic dermatitis. J Psychosom Res 1985;29:415–417.
22.
Munzel K, Schandry R: Atopic eczema: Psychophysiological reactivity with standardized stressors. Hautarzt 1990;41:606–611.
23.
Koehler T, Weber D: Psychophysiological reactions of patients with atopic dermatitis. J Psychosom Res 1992;36:391–394.
24.
Severity scoring of atopic dermatitis: The SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186:23–31.
25.
Spielberger C, Gorusch R, Lushene R: STAI, Manual for the State-Trait-Anxiety Inventory. Palo Alto, Consulting Psychologists Press, 1970.
26.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–571.
27.
Janke W, Debus G: Die Eigenschaftswörterliste EWL, Handanweisung. Göttingen, Hogrefe, 1978.
28.
Johannes B, Eichhorn C, Fischer F: A complex experimental assessment for objective description of hierarchical psychophysiological behavior as human regulatory phenotype. J Gravit Physiol 1994;1:P73–P74.
29.
Deter HC, Buchholz K, Schorr U, Schachinger H, Turan S, Sharma AM: Psychophysiological reactivity of salt-sensitive normotensive subjects. J Hypertens 1997;15:839–844.
30.
Steptoe A, Vogele C: Methodology of mental stress testing in cardiovascular research. Circulation 1991;83:II14–II24.
31.
Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, et al: Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151–H153.
32.
Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ: Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science 1981;213:220–222.
33.
Langewitz W, Ruddel H, Schachinger H, Lepper W, Mulder LJ, Veldman JH, van Roon A: Changes in sympathetic and parasympathetic cardiac activation during mental load: An assessment by spectral analysis of heart rate variability. Homeost Health Dis 1991;33:23–33.
34.
Critchley HD, Elliott R, Mathias CJ, Dolan RJ: Neural activity relating to generation and representation of galvanic skin conductance responses: A functional magnetic resonance imaging study. J Neurosci 2000;20:3033–3040.
35.
Schandry R: Lehrbuch der Psychophysiologie. München, Psychologie-Verlags-Union, 1988.
36.
Werner Y: The water content of the stratum corneum in patients with atopic dermatitis: Measurement with the Corneometer CM 420. Acta Derm Venereol 1986;66:281–284.
37.
Schwender R: Psychische Belastungen und Stressreaktionen bei Neurodermitikern und Psoriatikern; in Gieler U, Stangier U, Brähler E (eds): Hauterkrankungen in psychologischer Sicht. Göttingen, Hogrefe, 1993.
38.
Brown T, O’Leary T, Barlow D: Generalized anxiety disorder; in Barlow D (ed): Clinical Handbook of Psychological Disorders, ed 2. New York, Guilford Press, 1993, pp 139–188.
39.
Garrie EV, Garrie SA, Mote T: Anxiety and atopic dermatitis. J Consult Clin Psychol 1974;42:742.
40.
Fritzsche K, Ott J, Zschocke I, Scheib P, Burger T, Augustin M: Psychosomatic liaison service in dermatology: Need for psychotherapeutic interventions and their realization. Dermatology 2001;203:27–31.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.